JPWO2005110107A1 - Fermented milk - Google Patents

Fermented milk Download PDF

Info

Publication number
JPWO2005110107A1
JPWO2005110107A1 JP2005518120A JP2005518120A JPWO2005110107A1 JP WO2005110107 A1 JPWO2005110107 A1 JP WO2005110107A1 JP 2005518120 A JP2005518120 A JP 2005518120A JP 2005518120 A JP2005518120 A JP 2005518120A JP WO2005110107 A1 JPWO2005110107 A1 JP WO2005110107A1
Authority
JP
Japan
Prior art keywords
test example
fermented milk
bifidobacteria
milk
lactic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005518120A
Other languages
Japanese (ja)
Other versions
JP4283276B2 (en
Inventor
金忠 清水
金忠 清水
しずき 近藤
しずき 近藤
美絵 山越
美絵 山越
岩附 慧二
慧二 岩附
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of JPWO2005110107A1 publication Critical patent/JPWO2005110107A1/en
Application granted granted Critical
Publication of JP4283276B2 publication Critical patent/JP4283276B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms

Abstract

本発明は、ビフィズス菌等の乳酸菌を含有し、保存中における当該乳酸菌の生残性に優れた非加熱タイプの発酵乳を提供することを目的とする。本発明は、原料乳を乳酸菌を用いて発酵させて得られる発酵乳であって、ガラクトマンナン分解物を含有する、非加熱発酵乳である。An object of the present invention is to provide a non-heated fermented milk containing lactic acid bacteria such as bifidobacteria and excellent in the survival of the lactic acid bacteria during storage. The present invention is fermented milk obtained by fermenting raw milk using lactic acid bacteria, and is non-heated fermented milk containing a galactomannan degradation product.

Description

本発明は、ビフィズス菌等の乳酸菌を用いて発酵させた発酵乳に関する。  The present invention relates to fermented milk fermented using lactic acid bacteria such as bifidobacteria.

ビフィズス菌は、正常な消化を行う健康な人の腸内細菌として注目されており、その有用性についての研究も盛んになされている。
しかしながら、ビフィズス菌は偏性嫌気性菌であり、耐酸性に乏しく、死滅し易いことも知られている。したがって、ビフィズス菌を含有する発酵乳製品にあっては、製品中のビフィズス菌の死滅を防止することが課題である。
Bifidobacteria are attracting attention as an intestinal bacterium of healthy people who perform normal digestion, and research on their usefulness is also actively conducted.
However, it is also known that bifidobacteria are obligate anaerobes, have poor acid resistance, and are easily killed. Therefore, in fermented milk products containing bifidobacteria, it is an issue to prevent the death of bifidobacteria in the product.

下記特許文献1は、乳及び/又は乳製品からなる原料に、精製パルプ、穀類のふすま由来の繊維、穀類の糠由来の繊維、豆類の皮部等の不溶性の食物繊維を添加した後、殺菌し、ビフィズス菌等の乳酸菌を接種して発酵させることにより、保存中にビフィズス菌が死滅し難い発酵乳製品を製造する方法が記載されている。  Patent Document 1 below discloses that sterilization is performed after adding insoluble dietary fiber such as refined pulp, cereal bran fiber, cereal bran fiber, legume skin to raw materials comprising milk and / or dairy products. However, a method of producing a fermented dairy product in which bifidobacteria are difficult to kill during storage by inoculating and fermenting lactic acid bacteria such as bifidobacteria is described.

ガラクトマンナン分解物に関しては、下記特許文献2に、液状発酵乳または乳酸菌飲料を製造する際に、発酵済みの発酵乳に、ガラクトマンナン分解物とハイメトキシルペクチンを加え、pHを3.5〜4.5の範囲内に調整した後、均質処理を行うことにより、保存中における内容物の沈殿、分離、凝集等が抑えられた液状発酵乳または乳酸菌飲料を製造する方法が記載されている。
特開昭60−164432号公報 特開平3−285640号公報
Regarding the galactomannan degradation product, in the following Patent Document 2, when producing liquid fermented milk or lactic acid bacteria beverage, galactomannan degradation product and high methoxyl pectin are added to fermented fermented milk, and the pH is adjusted to 3.5-4. A method for producing a liquid fermented milk or a lactic acid bacteria beverage in which precipitation, separation, agglomeration, etc. of the content during storage is suppressed by performing a homogenous treatment after adjustment within the range of 0.5.
JP 60-164432 A JP-A-3-285640

通常、発酵乳製品の保存性としては、10℃で2週間以上が要求されるが、これに対応するためには、上記特許文献1の方法では、ビフィズス菌の死滅抑制効果が不十分であった。すなわち、上記特許文献1の実施例では、5℃で10日間保存したときにビフィズス菌の生残率が71〜85%程度を達成できることが示されているが、保存温度が10℃の場合には、これよりも生残率が悪くなることが予測され、発酵乳製品の保存性として満足できるものではなかった。
なお、上記特許文献2の方法では、発酵済みの発酵乳に対して、ガラクトマンナン分解物とハイメトキシルペクチンとの混合物を安定化剤として用いているに過ぎず、ビフィズス菌の死滅防止に関する記載は無い。
Usually, the storage stability of fermented dairy products is required at 10 ° C. for 2 weeks or more. However, in order to cope with this, the method of Patent Document 1 described above is insufficient in the effect of suppressing the killing of bifidobacteria. It was. That is, in the Example of the above-mentioned Patent Document 1, it is shown that the survival rate of bifidobacteria can be about 71 to 85% when stored at 5 ° C. for 10 days, but when the storage temperature is 10 ° C. Was predicted to have a worse survival rate than this, and was not satisfactory as the storage stability of fermented dairy products.
In addition, in the method of the said patent document 2, only the mixture of a galactomannan degradation product and a high methoxyl pectin is used as a stabilizer with respect to fermented fermented milk, and the description regarding the prevention of bifidobacteria death is described. No.

本発明は、上記事情に鑑みてなされたものであって、ビフィズス菌等の乳酸菌を含有する発酵乳であって、保存中におけるビフィズス菌の生残性に優れた非加熱発酵乳を提供することを目的とする。  The present invention has been made in view of the above circumstances, and provides fermented milk containing lactic acid bacteria such as bifidobacteria, which is excellent in the viability of bifidobacteria during storage and provides unheated fermented milk With the goal.

上記の目的を達成するために、本発明は以下の構成を採用した。
すなわち本発明は、乳酸菌で原料乳を発酵させたものであって、ガラクトマンナン分解物を含有する、非加熱発酵乳を提供するものである。
また本発明は、上記非加熱発酵乳であって、原料乳とガラクトマンナン分解物を含有する原料ミックスを加熱処理したものを乳酸菌で発酵したものを提供する。
本発明の非加熱発酵乳における前記乳酸菌は、ビフィズス菌、ビフィズス菌以外の乳酸菌、又はこれらの組合せとすることが可能である。尚、本願明細書において使用する「非加熱」とは、製造工程において加熱を行わないという意味ではなく、乳酸発酵の後に加熱を行わないという意味であり、発酵により増殖した乳酸菌を死滅させないことを意図している。
In order to achieve the above object, the present invention employs the following configuration.
That is, the present invention provides non-heated fermented milk obtained by fermenting raw milk with lactic acid bacteria and containing a galactomannan degradation product.
The present invention also provides the non-heated fermented milk, which is obtained by fermenting a raw mix containing raw milk and a galactomannan decomposition product with lactic acid bacteria.
The lactic acid bacteria in the non-heated fermented milk of the present invention can be bifidobacteria, lactic acid bacteria other than bifidobacteria, or a combination thereof. The term “non-heated” used in the present specification does not mean that heating is not performed in the production process, but means that heating is not performed after lactic acid fermentation, and does not kill lactic acid bacteria grown by fermentation. Intended.

本発明によれば、ビフィズス菌等の乳酸菌を含有する発酵乳において、保存中における当該乳酸菌の死滅が抑えられ、当該乳酸菌の生残性に優れた発酵乳が得られる。特に、ビフィズス菌およびビフィズス菌以外の乳酸菌により製造した混合発酵乳において、この効果が顕著である。  According to the present invention, in fermented milk containing lactic acid bacteria such as bifidobacteria, killing of the lactic acid bacteria during storage can be suppressed, and fermented milk having excellent survival of the lactic acid bacteria can be obtained. In particular, this effect is remarkable in mixed fermented milk produced by bifidobacteria and lactic acid bacteria other than bifidobacteria.

[図1]試験例で測定した保存日数とビフィズス菌数(logCFU/ml)との関係を示すグラフである。FIG. 1 is a graph showing the relationship between the number of storage days and the number of bifidobacteria (log CFU / ml) measured in a test example.

本発明の非加熱発酵乳は、原料乳を、ビフィズス菌等の乳酸菌を用いて発酵させて得られるものである。
原料乳としては、特に限定されず、生乳、脱脂乳、脱脂粉乳や全粉乳を溶解した還元乳等を例示することができる。原料乳には必要に応じて水を添加することができる。発酵乳の性状は、ハードヨーグルト、ソフトヨーグルト等の固形でもよく、ドリンクヨーグルト等の液状でもよい。
The non-heated fermented milk of the present invention is obtained by fermenting raw milk using lactic acid bacteria such as bifidobacteria.
The raw milk is not particularly limited, and examples thereof include raw milk, skim milk, skim milk powder, and reduced milk in which whole milk powder is dissolved. Water can be added to the raw milk as necessary. The properties of the fermented milk may be solid such as hard yogurt or soft yogurt or liquid such as drink yogurt.

発酵のスターターとしては、ビフィズス菌を用いることが好ましいが、ビフィズス菌以外の乳酸菌を併用してもよい。
本発明におけるビフィズス菌とは、ビフィドバクテリウム(Bifidobacterium)属に属する菌を指す。具体例としてはビフィドバクテリウム・ロンガム(Bifidobacterium longum)、ビフィドバクテリウム・ブレーベ(Bifidobacterium breve)等が挙げられる。
ビフィズス菌以外の乳酸菌としては、発酵乳のスターターとして公知の乳酸菌を用いることができる。具体例としては、ストレプトコッカス・サーモフィルス(Streptococcus thermophilus)、ストレプトコッカス・クレモリス(Streptococcus cremoris)、ラクトバチルス・ブルガリクス(Lactobacillus bulgaricus)、ラクトバチルス・カゼイ(Lactobacillus casei)、ラクトバチルス・ガセリ(Lactobacillus gasseri)等が挙げられる。
As a fermentation starter, bifidobacteria are preferably used, but lactic acid bacteria other than bifidobacteria may be used in combination.
The bifidobacteria in the present invention refers to a bacterium belonging to the genus Bifidobacterium. Specific examples include Bifidobacterium longum, Bifidobacterium breve and the like.
As lactic acid bacteria other than bifidobacteria, known lactic acid bacteria can be used as a starter for fermented milk. Specific examples include Streptococcus thermophilus, Streptococcus cremoris, Lactobacillus bulgaricus, Lactobacillus bacilli, Lactobacillus cecils, Is mentioned.

本発明の非加熱発酵乳は、上記特徴に加えてガラクトマンナン分解物を含有する。該ガラクトマンナン分解物は、例えばグアーガム、タラガム、ローカストビーンガム、タマリンドガムのうち一種もしくは二種以上に、ガラクトマンナナーゼあるいはセルラーゼに類する植物組織崩壊酵素を作用させて得られるので、ピーク分子量(分子量数分布におけるピーク分子量)が15000〜30000の範囲であるものが好ましい。
このようなガラクトマンナン分解物としては、市販品を用いることができる。具体的には、グアーガム、タマリンドガム等の植物由来の難消化性多糖類を水スラリー状にしたのち、グアーガムにはガラクトマンナナーゼを作用させ、タマリンドガムにはセルラーゼ等の食物繊維崩壊酵素を作用させることで、難消化性多糖類の部分分解物を調製して乾燥、精製したものが挙げられ、例えば、ピーク分子量20000のもの(商品名:サンファイバーR、太陽化学株式会社製)、あるいはピーク分子量24000のもの(商品名:ファイバロンS、大日本製薬株式会社製)等が挙げられる。
The non-heated fermented milk of the present invention contains a galactomannan degradation product in addition to the above characteristics. The galactomannan degradation product is obtained by allowing a plant tissue disrupting enzyme similar to galactomannanase or cellulase to act on one or more of guar gum, tara gum, locust bean gum, tamarind gum, for example, so that the peak molecular weight (number of molecular weights) Those having a peak molecular weight in the range of 15000 to 30000 are preferred.
A commercial item can be used as such a galactomannan decomposition product. Specifically, after making indigestible polysaccharides derived from plants such as guar gum and tamarind gum into water slurry, galactomannanase is allowed to act on guar gum and dietary fiber-disintegrating enzymes such as cellulase are allowed to act on tamarind gum Thus, a partially decomposed polysaccharide is prepared, dried and purified. For example, one having a peak molecular weight of 20000 (trade name: Sunfiber R, manufactured by Taiyo Kagaku Co., Ltd.), or a peak molecular weight. 24000 (trade name: Fiberlon S, manufactured by Dainippon Pharmaceutical Co., Ltd.) and the like.

本発明の非加熱発酵乳は、以下の方法で製造することができる。
まず、原料乳とガラクトマンナン分解物を含む原料ミックスを調製する。該原料ミックスには、原料乳およびガラクトマンナン分解物のほかに、所望に応じて油脂、糖類、水などのその他成分を配合することができる。
例えば、油脂として、バターやクリームなどの脂肪を含有する原料を配合することができる。糖類として、蔗糖、麦芽糖、ブドウ糖、果糖、デキストリン、還元麦芽糖等の通常の甘味剤を配合することができる。ハードヨーグルトを製造する場合は、予め膨潤したゼラチンおよび/または予め溶解した寒天溶液を配合することができる。ソフトヨーグルトを製造する場合は、ホエー蛋白質や増粘多糖類を配合することができる。ドリンクヨーグルトを製造する場合は、安定化剤としてハイメトキシルペクチンを0〜0.3質量%添加してもよいが、ハイメトキシルペクチンを全く含まないことが好ましい。
The non-heated fermented milk of the present invention can be produced by the following method.
First, a raw material mix containing raw material milk and a galactomannan decomposition product is prepared. In addition to the raw material milk and the galactomannan decomposition product, other components such as fats and oils, sugars, and water can be blended in the raw material mix as desired.
For example, raw materials containing fats such as butter and cream can be blended as fats and oils. As the saccharide, usual sweeteners such as sucrose, maltose, glucose, fructose, dextrin, and reduced maltose can be blended. When producing hard yogurt, pre-swelled gelatin and / or pre-dissolved agar solution can be blended. When producing soft yogurt, whey protein and thickening polysaccharide can be blended. When producing a drink yogurt, 0 to 0.3% by mass of high methoxyl pectin may be added as a stabilizer, but it is preferable that no high methoxyl pectin is contained.

原料ミックスを調製する方法は特に限定されず、例えば、原料乳に、ガラクトマンナン分解物の粉体、および所望に応じてその他成分を添加し、攪拌混合して原料ミックスを得ることができる。
ここで、原料ミックスにおける原料乳の配合率は、無脂乳固形分として1〜15質量%が好ましく、8〜15質量%がより好ましい。
ガラクトマンナン分解物の配合率は、原料ミックスの質量に対して、1〜10質量%の範囲とすることが好ましい。配合率が1質量%未満である場合には、ガラクトマンナン分解物の添加効果が十分に得られないおそれがあり、10質量%を超えると、得られる発酵乳において、のどごし等の食感に違和感を生じるおそれがある。より好ましい配合率は3〜6質量%の範囲である。
The method for preparing the raw material mix is not particularly limited. For example, the raw material milk can be obtained by adding the powder of the galactomannan decomposition product and other components as required and stirring and mixing them.
Here, 1-15 mass% is preferable as a non-fat milk solid content, and, as for the mixture ratio of the raw material milk in a raw material mix, 8-15 mass% is more preferable.
The blending ratio of the galactomannan decomposition product is preferably in the range of 1 to 10% by mass with respect to the mass of the raw material mix. If the blending ratio is less than 1% by mass, the effect of adding a galactomannan degradation product may not be sufficiently obtained, and if it exceeds 10% by mass, the resulting fermented milk has an uncomfortable texture such as a throat. May occur. A more preferable mixing ratio is in the range of 3 to 6% by mass.

次いで、原料ミックスに加熱殺菌処理を施す。殺菌方法および加熱条件は特に限定されないが、85〜140℃の加熱温度が好ましく、加熱時間は、バッチ式の場合は5〜15分が好ましく、HTST法の場合は2秒〜15分が好ましい。
続いて、加熱殺菌された原料ミックスに、乳酸菌種菌(スターターということもある)を接種して発酵を行う。スターターの接種量、発酵温度、発酵時間等の発酵条件は、スターターの種類、得ようとする発酵乳の種類や性状等に応じて適宜設定することができる。製品形態によっては、スターターを接種した後、容器に充填してから発酵させてもよく、発酵タンク内で発酵させてもよい。
Next, the raw mix is subjected to a heat sterilization treatment. The sterilization method and heating conditions are not particularly limited, but a heating temperature of 85 to 140 ° C. is preferable, and the heating time is preferably 5 to 15 minutes in the case of a batch type, and preferably 2 seconds to 15 minutes in the case of the HTST method.
Subsequently, the sterilized raw material mix is inoculated with a lactic acid bacteria inoculum (sometimes referred to as a starter) and fermented. Fermentation conditions such as the starter inoculation amount, fermentation temperature, and fermentation time can be appropriately set according to the type of starter and the type and properties of the fermented milk to be obtained. Depending on the product form, after inoculating the starter, the container may be filled and then fermented, or fermented in a fermentation tank.

発酵後、速やかに冷却して発酵乳を得る。製品の種類や性状によっては、冷却後に均質化する工程や、冷却後に調味液等の他の原料を添加して混合する工程を行ってもよい。
このようにして得られた発酵乳は、更なる加熱殺菌を施さず、発酵に使用したビフィズス菌等の乳酸菌を生菌として摂取できる生菌タイプの製品とすることができる。生菌タイプの製品は、10℃以下、好ましくは0〜5℃の低温下で保存、流通・販売される。
After fermentation, it is quickly cooled to obtain fermented milk. Depending on the type and properties of the product, a step of homogenizing after cooling, or a step of adding and mixing other raw materials such as seasoning liquid after cooling may be performed.
The fermented milk thus obtained can be made into a viable cell type product that can be ingested as a viable lactic acid bacterium such as bifidobacteria used for fermentation without further heat sterilization. Live bacteria type products are stored, distributed and sold at a low temperature of 10 ° C. or lower, preferably 0 to 5 ° C.

このようにして得られる非加熱発酵乳は、スターターを接種して発酵させる工程におけるビフィズス菌等の乳酸菌の生育が促進され、より多くの乳酸菌を含有する製品が得られる。
また、製造後の発酵乳を低温で保存する際の乳酸菌の死滅が抑制され、保存中も発酵乳中の乳酸菌数を高く維持することができる。
また、ガラクトマンナン分解物は水溶性であるため、ガラクトマンナン分解物の添加による発酵乳の風味に対する悪影響が生じ難いため、風味が良好な発酵乳が得られる。
In the non-heated fermented milk thus obtained, the growth of lactic acid bacteria such as bifidobacteria in the step of inoculating the starter is promoted, and a product containing more lactic acid bacteria is obtained.
Moreover, the death of the lactic acid bacteria at the time of preserve | storing the fermented milk after manufacture at low temperature is suppressed, and the number of lactic acid bacteria in fermented milk can be maintained high also during a preservation | save.
In addition, since the galactomannan degradation product is water-soluble, adverse effects on the flavor of the fermented milk due to the addition of the galactomannan degradation product are unlikely to occur, and thus fermented milk having a good flavor can be obtained.

(試験例1〜3および対照試験例1〜3)
・菌株
下記試験例1および対照試験例1では、ビフィズス菌としてビフィドバクテリウム・ロンガム(Bifidobacterium longum)(寄託番号;FERM BP−7787)を用いた。
下記試験例2および対照試験例2では、ビフィズス菌以外の乳酸菌として、ストレプトコッカス・サーモフィルス(Streptococcus thermophilus)(寄託番号;FERM P−17215)を用いた。
下記試験例3および対照試験例3では、ビフィズス菌以外の乳酸菌として、ラクトバチルス・ガセリ(Lactobacillus gasseri)(独立行政法人 理化学研究所 微生物系統保存施設 分譲株の菌株番号;JCM1131)を用いた。
(Test Examples 1 to 3 and Control Test Examples 1 to 3)
-Strains In Test Example 1 and Control Test Example 1 below, Bifidobacterium longum (deposit number: FERM BP-7787) was used as the Bifidobacterium.
In Test Example 2 and Control Test Example 2 below, Streptococcus thermophilus (Deposit Number: FERM P-17215) was used as a lactic acid bacterium other than Bifidobacterium.
In the following Test Example 3 and Control Test Example 3, Lactobacillus gasseri (Lactobacillus gasseri, a strain number of a stock of microorganisms stored in the Institute of Physical and Chemical Research; JCM1131) was used as a lactic acid bacterium other than bifidobacteria.

・種菌(スターター)の調製
酵母エキス0.2質量%、脱脂粉乳11質量%、残部は水からなる培地に、115℃15分の殺菌処理を施した後、上記3種の菌株をそれぞれ3質量%接種した。そして、37℃でpH4.6前後になるまで培養したものを、以下の発酵テストにおけるスターターとした。
-Preparation of inoculum (starter) Yeast extract 0.2 mass%, skimmed milk powder 11 mass%, and the balance is water sterilized at 115 ° C for 15 minutes, then 3 masses of each of the above three strains. % Vaccination. And what was culture | cultivated until it became pH 4.6 around 37 degreeC was used as the starter in the following fermentation tests.

・発酵テスト
試験例1,2,3では、脱脂粉乳11質量%、およびガラクトマンナン分解物(商品名:サンファイバーR、ピーク分子量20,000程度、太陽化学社製)3.5質量%を含有し、残部は水からなる試験培地を、115℃で15分殺菌した後、上記で調製したスターターを3質量%接種した。
対照試験例1,2,3では、ガラクトマンナン分解物を添加しない他は試験例1と同様にして、試験培地にスターターを接種した。
接種後、37℃で12時間発酵させた後、急冷して発酵乳を得た。
Fermentation test In Test Examples 1, 2, and 3, containing 11% by mass of skim milk powder and 3.5% by mass of a galactomannan degradation product (trade name: Sunfiber R, peak molecular weight of about 20,000, manufactured by Taiyo Chemical Co., Ltd.) The remainder was sterilized at 115 ° C. for 15 minutes, and then inoculated with 3% by mass of the starter prepared above.
In Control Test Examples 1, 2, and 3, the test medium was inoculated with a starter in the same manner as in Test Example 1, except that the galactomannan degradation product was not added.
After inoculation, the mixture was fermented at 37 ° C. for 12 hours and then rapidly cooled to obtain fermented milk.

・評価
得られた発酵乳におけるpH、乳酸酸度(単位;%)、およびビフィズス菌の菌数(単位;CFU/ml)を測定した。ビフィズス菌数の測定はRCA(ReinforcedClostridialAgar,Oxoid社製)平板で行った。ビフィズス菌以外の乳酸菌数の測定はBCP寒天平板(栄研器材社製)で行った。また、対照試験例1〜3の菌数の測定値をそれぞれ1としたときの、試験例1〜3の菌数の割合(試験例の菌数/対照試験例の菌数)を菌数倍率として算出した。これらの結果を表1に示す。
Evaluation The pH, lactate acidity (unit:%), and the number of bifidobacteria (unit: CFU / ml) in the obtained fermented milk were measured. The number of bifidobacteria was measured on an RCA (Reinformed ClostritionalAgar, Oxoid) flat plate. The number of lactic acid bacteria other than Bifidobacteria was measured with a BCP agar plate (Eiken Equipment Co., Ltd.). In addition, the ratio of the number of bacteria in Test Examples 1 to 3 (the number of bacteria in Test Example / the number of bacteria in Control Test Example) when the measured value of the number of bacteria in Control Test Examples 1 to 1 is 1, respectively. Calculated as These results are shown in Table 1.

Figure 2005110107
Figure 2005110107

表1の結果より、試験例1〜3はいずれも、それぞれ対応する対照試験例1〜3に比較して、発酵乳のpHが低下し、乳酸酸度が上昇した。また菌数も増加し発酵時の各菌の生育も促進された。
特に試験例1は、試験例2,3に比べて菌数倍率が大きかった。
From the results shown in Table 1, in each of Test Examples 1 to 3, the pH of the fermented milk decreased and the lactic acid acidity increased compared to the corresponding Control Test Examples 1 to 3, respectively. In addition, the number of bacteria increased, and the growth of each bacteria during fermentation was promoted.
In particular, Test Example 1 had a larger bacterial count magnification than Test Examples 2 and 3.

(試験例4,5)
試験例4では、上記試験例1において、ガラクトマンナン分解物に代えて、水溶性の食物繊維である難消化性デキストリン(商品名:パインファイバー、松谷化学工業株式会社製)を用いた他は試験例1と同様にして発酵テストを行った。
試験例5では、上記試験例1において、ガラクトマンナン分解物に代えて、水溶性の食物繊維であるイヌリン(商品名:ラフテリンST チコリファイバー、オラフティ社製)を用いた他は試験例1と同様にして発酵テストを行った。
(Test Examples 4 and 5)
In Test Example 4, the test except that indigestible dextrin (trade name: Pine Fiber, manufactured by Matsutani Chemical Industry Co., Ltd.), which is a water-soluble dietary fiber, was used in place of the galactomannan degradation product in Test Example 1 above. A fermentation test was conducted in the same manner as in Example 1.
In Test Example 5, the same procedure as in Test Example 1 except that inulin (trade name: Raftelin ST chicory fiber, manufactured by Olafty), which is a water-soluble dietary fiber, was used in place of the galactomannan degradation product in Test Example 1 above. A fermentation test was conducted.

試験例1と同様にしてpH、乳酸酸度(単位;%)、およびビフィズス菌の菌数(単位;CFU/ml)を測定した。これらの結果を表2に示す。
なお表2には、試験例1および対照試験例1の結果も合わせて示す。
In the same manner as in Test Example 1, pH, lactic acidity (unit:%), and the number of bifidobacteria (unit: CFU / ml) were measured. These results are shown in Table 2.
Table 2 also shows the results of Test Example 1 and Control Test Example 1.

Figure 2005110107
Figure 2005110107

表2の結果より、対照試験例1と比較して、ガラクトマンナン分解物を用いた試験例1では発酵乳のpHの低下、乳酸酸度の上昇、およびビフィズス菌の生育促進の効果が認められたものの、試験例4,5ではこれらの効果は認められなかった。  From the results of Table 2, compared to Control Test Example 1, in Test Example 1 using a galactomannan degradation product, the effects of lowering the pH of fermented milk, increasing the lactic acid acidity, and promoting the growth of bifidobacteria were observed. However, in Test Examples 4 and 5, these effects were not observed.

(試験例6〜9)
上記試験例1において、試験培地におけるガラクトマンナン分解物の濃度を1質量%、3質量%、5質量%、および7質量%に変化させた他は同様にして発酵テストを行った。
試験例1と同様にしてpH、乳酸酸度(単位;%)、およびビフィズス菌の菌数(単位;CFU/ml)を測定した。これらの結果を表3に示す。
なお表3には、対照試験例1の結果も合わせて示す。
(Test Examples 6 to 9)
A fermentation test was conducted in the same manner as in Test Example 1 except that the concentration of the galactomannan degradation product in the test medium was changed to 1% by mass, 3% by mass, 5% by mass, and 7% by mass.
In the same manner as in Test Example 1, pH, lactic acidity (unit:%), and the number of bifidobacteria (unit: CFU / ml) were measured. These results are shown in Table 3.
Table 3 also shows the results of Control Test Example 1.

Figure 2005110107
Figure 2005110107

表3に示されるように、ガラクトマンナン分解物の添加濃度が高くなるに従って、発酵乳のpHがより低下し、乳酸酸度がより上昇し、各菌種の生育がより促進された。  As shown in Table 3, as the concentration of the galactomannan degradation product increased, the pH of the fermented milk decreased, the lactic acid acidity increased, and the growth of each bacterial species was further promoted.

(試験例10および対照試験例10)
・菌株
試験例10および対照試験例10では、発酵にビフィズス菌としてビフィドバクテリウム・ロンガム(Bifidobacterium longum)(寄託番号;FERM BP−7787)を用いるとともに、ビフィズス菌以外の乳酸菌としてストレプトコッカス・クレモリス(Streptococcus cremoris、ハンゼン社製)を用いた。
(Test Example 10 and Control Test Example 10)
-Strain In Test Example 10 and Control Test Example 10, Bifidobacterium longum (deposit number: FERM BP-7787) was used as the bifidobacteria for fermentation, and Streptococcus cremolith (as lactic acid bacteria other than Bifidobacteria) Streptococcus cremoris (manufactured by Hansen) was used.

・種菌(スターター)の調製
酵母エキス0.2質量%、脱脂粉乳11質量%、残部は水からなる培地1000mlに、90℃30分の殺菌処理を施した後、上記ビフィドバクテリウム・ロンガムを50ml接種し、37℃で6時間培養してスターターとした。
一方,酵母エキス0.2質量%、還元脱脂乳10質量%、残部は水からなる培地1000mlに、90℃30分間の殺菌処理を施した後、上記ストレプトコッカス・クレモリスを30ml接種し、30℃で16時間培養してスターターとした。
-Preparation of inoculum (starter) Yeast extract 0.2% by mass, skim milk powder 11% by mass, and the remainder is treated with water at 1000C for 30 minutes at 90 ° C, and then the above Bifidobacterium longum A starter was prepared by inoculating 50 ml and culturing at 37 ° C. for 6 hours.
On the other hand, the yeast extract 0.2% by mass, the reduced skim milk 10% by mass, and the balance 1000 ml of water was sterilized at 90 ° C. for 30 minutes, and then 30 ml of the Streptococcus cremoris was inoculated at 30 ° C. It was cultured for 16 hours to prepare a starter.

・発酵テスト
試験例10では、ガラクトマンナン分解物(商品名:サンファイバーR、ピーク分子量20,000程度、太陽化学社製)、脱脂粉乳、全粉乳及び蔗糖を水に溶解して、乳脂肪0.3質量%、無脂乳固形分8.0質量%、蔗糖4.5質量%、ガラクトマンナン分解物3.5質量%の原料ミックス1を調製した。この原料ミックス1を130℃で2秒間殺菌し、33℃に冷却した。
この原料ミックス1に、上記で調製したビフィドバクテリウム・ロンガムのスターターを1質量%、及びストレプトコッカス・クレモリスのスターターを1.5質量%添加し、31℃でpH4.6前後になるまで発酵させ、急冷して発酵乳を得た。
一方、対照試験例10では、ガラクトマンナン分解物を添加せず、その分だけ水の添加量を増加させた他は試験例10と同様にして原料ミックス2を調製し、同様に2種のスターターを接種した後、発酵、急冷して発酵乳を得た。
Fermentation test In Test Example 10, a galactomannan degradation product (trade name: Sunfiber R, peak molecular weight of about 20,000, manufactured by Taiyo Kagaku Co., Ltd.), skim milk powder, whole powdered milk and sucrose are dissolved in water to give 0 milk fat. A raw material mix 1 containing 3 mass%, non-fat milk solid content 8.0 mass%, sucrose 4.5 mass%, and galactomannan degradation product 3.5 mass% was prepared. This raw material mix 1 was sterilized at 130 ° C. for 2 seconds and cooled to 33 ° C.
1% by mass of the starter of Bifidobacterium longum prepared above and 1.5% by mass of the starter of Streptococcus cremoris are added to the raw material mix 1 and fermented until the pH reaches about 4.6 at 31 ° C. Then, it was rapidly cooled to obtain fermented milk.
On the other hand, in Control Test Example 10, the raw material mix 2 was prepared in the same manner as in Test Example 10 except that the galactomannan degradation product was not added and the amount of water added was increased by that amount, and two starters were prepared in the same manner. After inoculation, fermented milk was obtained by fermentation and rapid cooling.

・評価
急冷直後、および10℃で保存して7日後、14日後、21日後、28日後の発酵乳について、試験例1と同様にしてpH、乳酸酸度(単位;%)、およびビフィズス菌の菌数(単位;CFU/ml)を測定した。また、急冷直後(保存日数0)の菌数の測定値を1としたときの、10℃保存後の菌数の割合(保存後の菌数/急冷直後の菌数)を生残率として算出した。試験例10の結果を表4に示し、対照試験例10の結果を表5に示す。また生残性の結果として、保存日数とビフィズス菌数(logCFU/ml)との関係を図1のグラフに示す。
Evaluation Immediately after rapid cooling and after 7 days, 14 days, 21 days, and 28 days after storage at 10 ° C., the pH, lactic acidity (unit:%), and bifidobacteria bacteria as in Test Example 1 The number (unit: CFU / ml) was measured. In addition, the ratio of the number of bacteria after storage at 10 ° C. (the number of bacteria after storage / the number of bacteria immediately after rapid cooling) when the measured value of the number of bacteria immediately after quenching (0 days of storage) is 1, is calculated as the survival rate. did. The results of Test Example 10 are shown in Table 4, and the results of Control Test Example 10 are shown in Table 5. As a result of survival, the relationship between the storage days and the number of bifidobacteria (log CFU / ml) is shown in the graph of FIG.

Figure 2005110107
Figure 2005110107

Figure 2005110107
Figure 2005110107
Figure 2005110107
Figure 2005110107

表4,5および図1の結果に示されるように、原料ミックスにガラクトマンナン分解物を添加した試験例10では、ガラクトマンナン分解物を添加しない対照試験例10に比べて、製造直後の発酵乳におけるビフィズス菌数が高く、10℃の低温保存中におけるビフィズス菌の減少(生残率の減少)も抑えられた。  As shown in the results of Tables 4 and 5 and FIG. 1, in Test Example 10 in which a galactomannan degradation product was added to the raw material mix, fermented milk immediately after production was compared to Control Test Example 10 in which no galactomannan degradation product was added. The number of bifidobacteria was high, and the decrease of bifidobacteria during the low-temperature storage at 10 ° C. (decrease in survival rate) was also suppressed.

(試験例11、12および対照試験例12)
・試験例11では、前記試験例10と同様にして発酵テストを行った。
・試験例12では、試験例10と同じ原料を用いたが、原料ミックスにガラクトマンナン分解物を添加せず、他の原料の配合量を変えることによって、乳脂肪0.4質量%、無脂乳固形分10.4質量%、蔗糖4.5質量%の原料ミックス3を調製した。この原料ミックス3を試験例10と同様に殺菌、冷却した後、前記試験例10と同じ2種のスターターを添加し、発酵、急冷して発酵乳を得た。これとは別に、水にガラクトマンナン分解物(商品名:サンファイバーR、ピーク分子量20,000程度、太陽化学社製)を15質量%となるように溶解し、130℃で2秒間殺菌したガラクトマンナン分解物溶液を準備した。そして、急冷後の発酵乳78質量部と該ガラクトマンナン分解物溶液22質量部とを混合して、ガラクトマンナン分解物が後添加された発酵乳を得た。
・対照試験例12では、試験例12においてガラクトマンナン分解物溶液の代わりに130℃で2秒間殺菌した水を用いた。すなわち、急冷後の発酵乳78質量部と水22質量部とを混合して、ガラクトマンナン分解物無添加の発酵乳を得た。
(Test Examples 11 and 12 and Control Test Example 12)
-In Test Example 11, a fermentation test was performed in the same manner as in Test Example 10.
In Test Example 12, the same raw material as in Test Example 10 was used, but by adding no galactomannan degradation product to the raw material mix and changing the blending amount of other raw materials, 0.4% by mass of milk fat and non-fat A raw material mix 3 having a milk solid content of 10.4% by mass and sucrose of 4.5% by mass was prepared. This raw material mix 3 was sterilized and cooled in the same manner as in Test Example 10, and then the same two types of starters as in Test Example 10 were added, followed by fermentation and rapid cooling to obtain fermented milk. Separately, a galactomannan degradation product (trade name: Sunfiber R, peak molecular weight of about 20,000, manufactured by Taiyo Chemical Co., Ltd.) is dissolved in water so as to be 15% by mass, and sterilized at 130 ° C. for 2 seconds. A mannan degradation product solution was prepared. And 78 mass parts of fermented milk after quenching and 22 mass parts of this galactomannan degradation product solution were mixed, and fermented milk to which the galactomannan degradation product was added afterwards was obtained.
In Control Test Example 12, water sterilized at 130 ° C. for 2 seconds was used instead of the galactomannan degradation product solution in Test Example 12. That is, 78 parts by mass of fermented milk after quenching and 22 parts by mass of water were mixed to obtain fermented milk without addition of a galactomannan decomposition product.

・評価
急冷直後、および10℃で保存して14日後の各発酵乳について、試験例1と同様にしてpH、乳酸酸度(単位;%)、およびビフィズス菌の菌数(単位;CFU/ml)を測定した。また、急冷直後(保存日数0)の菌数の測定値を1としたときの、10℃保存後の菌数の割合(保存後の菌数/急冷直後の菌数)を生残率として算出した。その結果を表6に示す。
-Evaluation For each fermented milk immediately after quenching and after 14 days of storage at 10 ° C., the pH, the degree of lactic acid (unit:%), and the number of bifidobacteria (unit: CFU / ml) were the same as in Test Example 1. Was measured. In addition, the ratio of the number of bacteria after storage at 10 ° C. (the number of bacteria after storage / the number of bacteria immediately after rapid cooling) when the measured value of the number of bacteria immediately after quenching (0 days of storage) is 1, is calculated as the survival rate. did. The results are shown in Table 6.

Figure 2005110107
Figure 2005110107

表6の結果より、ガラクトマンナン分解物を発酵後に添加した試験例12に比べて、ガラクトマンナン分解物を原料ミックスに添加した後に発酵を行った試験例11は、製造直後の発酵乳におけるビフィズス菌数が高く、10℃の低温保存中におけるビフィズス菌の減少(生残率の減少)も抑えられた。
また、ガラクトマンナン分解物を発酵後に添加した試験例12は、ガラクトマンナン分解物を添加しなかった対照試験例12と比べて、製造直後の発酵乳におけるビフィズス菌数および10℃の低温保存中におけるビフィズス菌において、大きな差は見られなかった。
From the results of Table 6, compared to Test Example 12 in which the galactomannan degradation product was added after fermentation, Test Example 11 in which fermentation was performed after the galactomannan degradation product was added to the raw material mix was Bifidobacterium in fermented milk immediately after production. The number of bifidobacteria during storage at a low temperature of 10 ° C. (decrease in survival rate) was also suppressed.
In addition, in Test Example 12 in which the galactomannan degradation product was added after fermentation, compared to Control Test Example 12 in which the galactomannan degradation product was not added, the number of bifidobacteria in the fermented milk immediately after production and during low-temperature storage at 10 ° C. There was no significant difference in bifidobacteria.

(試験例13、14および対照試験例13)
・試験例13では、生乳にガラクトマンナン分解物を添加混合して、乳脂肪3.0質量%、無脂乳固形分9.0質量%、ガラクトマンナン分解物3.5質量%の原料ミックス4を調製した。この原料ミックス4を130℃で2秒間殺菌し、33℃に冷却した。
この原料ミックス4に、試験例10と同じ2種のスターターを接種し、試験例10と同様にして発酵、急冷して発酵乳を得た。
・試験例14では、ガラクトマンナン分解物に代えて精製繊維(商品名;アビセル、旭化成社製)1.0質量%を添加した他は試験例13と同様にして原料ミックス5を調製し、同様に2種のスターターを接種した後、発酵、急冷して発酵乳を得た。
・対照試験例13では、ガラクトマンナン分解物を添加しなかった他は試験例13と同様にして原料ミックス6を調製し、同様に2種のスターターを接種した後、発酵、急冷して発酵乳を得た。
(Test Examples 13 and 14 and Control Test Example 13)
In Test Example 13, a galactomannan degradation product was added to and mixed with raw milk, and a raw material mix 4 containing 3.0% by mass of milk fat, 9.0% by mass of nonfat milk solids, and 3.5% by mass of galactomannan degradation product Was prepared. This raw material mix 4 was sterilized at 130 ° C. for 2 seconds and cooled to 33 ° C.
The raw material mix 4 was inoculated with the same two types of starters as in Test Example 10, and fermented and quenched in the same manner as in Test Example 10 to obtain fermented milk.
In Test Example 14, the raw material mix 5 was prepared in the same manner as in Test Example 13 except that 1.0% by mass of purified fiber (trade name; Avicel, manufactured by Asahi Kasei Co., Ltd.) was added instead of the galactomannan degradation product. After inoculating 2 kinds of starters, fermented milk was obtained by fermentation and rapid cooling.
In Control Test Example 13, the raw material mix 6 was prepared in the same manner as in Test Example 13 except that the galactomannan degradation product was not added, and inoculated with two kinds of starters in the same manner, and then fermented and rapidly cooled to fermented milk. Got.

・評価
急冷直後、および10℃で保存して14日後の各発酵乳について、試験例1と同様にしてpH、乳酸酸度(単位;%)、およびビフィズス菌の菌数(単位;CFU/ml)を測定した。また、急冷直後(保存日数0)の菌数の測定値を1としたときの、10℃保存後の菌数の割合(保存後の菌数/急冷直後の菌数)を生残率として算出した。その結果を表7に示す。

Figure 2005110107
-Evaluation For each fermented milk immediately after quenching and after 14 days of storage at 10 ° C., the pH, the degree of lactic acid (unit:%), and the number of bifidobacteria (unit: CFU / ml) were the same as in Test Example 1. Was measured. In addition, the ratio of the number of bacteria after storage at 10 ° C. (the number of bacteria after storage / the number of bacteria immediately after rapid cooling) when the measured value of the number of bacteria immediately after quenching (0 days of storage) is 1, is calculated as the survival rate. did. The results are shown in Table 7.
Figure 2005110107

表7の結果より、ガラクトマンナン分解物以外の精製繊維を添加した試験例14および食物繊維を添加しなかった対照試験例13に比べて、ガラクトマンナン分解物を原料ミックスに添加した試験例13は、製造直後の発酵乳におけるビフィズス菌数が高く、10℃の低温保存中におけるビフィズス菌の減少(生残率の減少)も抑えられた。  From the results of Table 7, the test example 13 in which the galactomannan degradation product was added to the raw material mix was compared with the test example 14 in which the purified fiber other than the galactomannan degradation product was added and the control test example 13 in which the dietary fiber was not added. The number of bifidobacteria in the fermented milk immediately after production was high, and the decrease in bifidobacteria (reduction in survival rate) during low-temperature storage at 10 ° C. was also suppressed.

本例では、原料ミックスとして前記試験例10と同様の原料ミックス1を用いた。またスターターとして前記試験例10と同様に調製したビフィドバクテリウム・ロンガムのスターター及びストレプトコッカス・クレモリスのスターターを用いた。
試験例10と同様にして調製した2000リットルの原料ミックス1を130℃で2秒間殺菌処理し、40℃に冷却した。これにビフィドバクテリウム・ロンガムのスターター2リットルとストレプトコッカス・クレモリスのスターター3リットルを接種し、31℃で13時間発酵させた。この後、直ちに撹拌冷却し、冷却した発酵乳を15MPaの圧力で均質化して、容量120mlの樹脂製容器に充填し、密封してドリンクヨーグルトを得た。
製造直後の発酵乳(ドリンクヨーグルト)について、試験例1と同様にして評価したところ、pH4.6、乳酸酸度0.68%、ビフィズス菌数4.0×10CFU/mlであった。またB型粘度計を使用し、2番ローターによって60回転/分、10℃の条件で測定した粘度は35mPa・sであった。
この発酵乳を10℃で21日間保存したときのビフィズス菌数は1.2×10CFU/mlであり、生残率は30%であった。
In this example, the same raw material mix 1 as in Test Example 10 was used as the raw material mix. As the starter, a starter of Bifidobacterium longum and a starter of Streptococcus cremollis prepared in the same manner as in Test Example 10 were used.
A 2000-liter raw material mix 1 prepared in the same manner as in Test Example 10 was sterilized at 130 ° C. for 2 seconds and cooled to 40 ° C. This was inoculated with 2 liters of Bifidobacterium longum starter and 3 liters of Streptococcus cremoris starter and fermented at 31 ° C. for 13 hours. Thereafter, the mixture was immediately stirred and cooled, and the cooled fermented milk was homogenized at a pressure of 15 MPa, filled in a resin container having a capacity of 120 ml, and sealed to obtain a drink yogurt.
The fermented milk (drink yogurt) immediately after production was evaluated in the same manner as in Test Example 1. The pH was 4.6, the lactic acid acidity was 0.68%, and the number of bifidobacteria was 4.0 × 10 8 CFU / ml. Further, using a B-type viscometer, the viscosity measured at 60 ° / min and 10 ° C. with a No. 2 rotor was 35 mPa · s.
When this fermented milk was stored at 10 ° C. for 21 days, the number of bifidobacteria was 1.2 × 10 8 CFU / ml, and the survival rate was 30%.

・菌株
本例では、発酵にビフィズス菌としてビフィドバクテリウム・ロンガム(Bifidobacteium longum)(寄託番号;FERM BP−7787)を用いるとともに、ビフィズス菌以外の乳酸菌としてストレプトコッカス・サーモフィルス(Streptococcus thermophilus、ハンゼン社製)およびラクトバチルス・ブルガリクス(Lacobacillus bulgaricus、ハンゼン社製)を用いた。
・種菌(スターター)の調製
酵母エキス0.2質量%、脱脂粉乳11質量%、残部は水からなる培地1000mlに、90℃30分の殺菌処理を施した後、上記ビフィドバクテリウム・ロンガムを50ml接種し、37℃で6時間培養してスターターとした。
一方、還元脱脂乳10質量%、残部は水からなる培地1000mlに、90℃30分間の殺菌処理を施した後、上記ストレプトコッカス・サーモフィルス25mlとラクトバチルス・ブルガリクス25mlとの混合物(合計50ml)を接種し、42℃で5時間培養してスターターとした。
-Strain In this example, Bifidobacterium longum (deposit number: FERM BP-7787) is used as the bifidobacteria for fermentation, and Streptococcus thermophilus (Streptococcus thermophilus, And Lactobacillus bulgaricus (manufactured by Hansen).
-Preparation of inoculum (starter) Yeast extract 0.2% by mass, skim milk powder 11% by mass, and the remainder is treated with water at 1000C for 30 minutes at 90 ° C, and then the above Bifidobacterium longum A starter was prepared by inoculating 50 ml and culturing at 37 ° C. for 6 hours.
On the other hand, 10 ml of reduced skimmed milk and the balance 1000 ml of a medium consisting of water were sterilized at 90 ° C. for 30 minutes, and then a mixture of 25 ml of Streptococcus thermophilus and 25 ml of Lactobacillus bulgaricus (total 50 ml) And incubating at 42 ° C. for 5 hours to prepare a starter.

・発酵乳の製造
本例では、前記試験例14と同様の原料ミックス4を用いた。
試験例13と同様にして調製した2000リットルの原料ミックス4を70℃に加温し、15MPaの圧力で均質化し、90℃で10分間殺菌し、40℃に冷却した。
この原料ミックス4(2000リットル)に、上記で調製したビフィドバクテリウム・ロンガムのスターターを3リットル、及び上記で調製したストレプトコッカス・サーモフィルスとラクトバチルス・ブルガリクスとの混合スターター1.2リットルを接種し、容量500mlの樹脂製容器に充填し、37℃で5時間発酵させ、急冷して発酵乳を得た。
得られた発酵乳について、試験例1と同様にして評価したところ、pH4.55、乳酸酸度0.75%、ビフィズス菌数3.8×10CFU/ml、ストレプトコッカス・サーモフィルスの菌数6.8×10CFU/ml、とラクトバチルス・ブルガリクスの菌数3.4×10CFU/mlであった。
この発酵乳を10℃で21日間保存したときのビフィズス菌数は1.5×10CFU/mlであり、生残率は39.5%であった。
-Manufacture of fermented milk In this example, the raw material mix 4 similar to the said test example 14 was used.
A 2000-liter raw material mix 4 prepared in the same manner as in Test Example 13 was heated to 70 ° C., homogenized at a pressure of 15 MPa, sterilized at 90 ° C. for 10 minutes, and cooled to 40 ° C.
In this raw mix 4 (2000 liters), 3 liters of the starter of Bifidobacterium longum prepared above and 1.2 liters of the mixed starter of Streptococcus thermophilus and Lactobacillus bulgaricx prepared above Inoculated, filled into a 500 ml resin container, fermented at 37 ° C. for 5 hours, and rapidly cooled to obtain fermented milk.
The obtained fermented milk was evaluated in the same manner as in Test Example 1. As a result, pH 4.55, lactic acidity 0.75%, bifidobacteria count 3.8 × 10 8 CFU / ml, Streptococcus thermophilus bacteria count 6 And 8 × 10 8 CFU / ml, and the number of Lactobacillus bulgaricus was 3.4 × 10 7 CFU / ml.
When this fermented milk was stored at 10 ° C. for 21 days, the number of bifidobacteria was 1.5 × 10 8 CFU / ml, and the survival rate was 39.5%.

本発明によれば、保存中の乳酸菌の死滅が抑えられた非加熱発酵乳を得ることができる。  According to the present invention, it is possible to obtain non-heated fermented milk in which killing of lactic acid bacteria during storage is suppressed.

Claims (3)

乳酸菌で原料乳を発酵させたものであって、ガラクトマンナン分解物を含有する、非加熱発酵乳。Non-heated fermented milk obtained by fermenting raw milk with lactic acid bacteria and containing a galactomannan degradation product. 原料乳とガラクトマンナン分解物を含有する原料ミックスを加熱処理したものを、乳酸菌で発酵した、請求項1に記載の非加熱発酵乳。The non-heated fermented milk of Claim 1 which fermented with lactic acid bacteria what heat-processed the raw material mix containing raw material milk and a galactomannan decomposition product. 前記乳酸菌が、ビフィズス菌、ビフィズス菌以外の乳酸菌、又はこれらの組合せである、請求項1又は2に記載の非加熱発酵乳。The non-heated fermented milk according to claim 1 or 2, wherein the lactic acid bacteria are bifidobacteria, lactic acid bacteria other than bifidobacteria, or a combination thereof.
JP2005518120A 2004-05-19 2005-03-30 Fermented milk Expired - Fee Related JP4283276B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004149255 2004-05-19
JP2004149255 2004-05-19
PCT/JP2005/006135 WO2005110107A1 (en) 2004-05-19 2005-03-30 Fermented milk

Publications (2)

Publication Number Publication Date
JPWO2005110107A1 true JPWO2005110107A1 (en) 2008-05-22
JP4283276B2 JP4283276B2 (en) 2009-06-24

Family

ID=35393903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005518120A Expired - Fee Related JP4283276B2 (en) 2004-05-19 2005-03-30 Fermented milk

Country Status (2)

Country Link
JP (1) JP4283276B2 (en)
WO (1) WO2005110107A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008010184A (en) * 2007-02-13 2009-03-05 Morinaga Milk Industry Co Ltd Method of producing fermented milk using novel lactic acid bacterium.
US8277856B2 (en) 2008-03-27 2012-10-02 Morinaga Milk Industry Co., Ltd. Method of producing acidic lactic acid bacteria beverage
FR2933272B1 (en) * 2008-07-04 2014-11-07 Claude Dumarche PROCESS FOR THE PREPARATION OF A LEAVEN FROM RAW MILK, LEAVEN OBTAINED BY THIS PROCESS AND USE OF THE SAME FOR MANUFACTURING A MILK PRODUCT
WO2010119956A1 (en) * 2009-04-17 2010-10-21 物産フードサイエンス株式会社 Lactobacillus survival rate improvement agent and storage method using same
IN2012DN02283A (en) * 2009-09-02 2015-08-21 Meiji Co Ltd
JP5690257B2 (en) * 2011-11-04 2015-03-25 株式会社 伊藤園 Lactic acid bacteria-containing beverage and method for producing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60164432A (en) * 1984-02-06 1985-08-27 Morinaga Milk Ind Co Ltd Preparation of fermented dairy product containing bacterium belonging to genus bifidobacterium
JP2603470B2 (en) * 1987-04-28 1997-04-23 大日本製薬株式会社 Foods containing partial digests of indigestible polysaccharides
JP2816726B2 (en) * 1989-11-10 1998-10-27 カルピス株式会社 Composition for improving intestinal environment
JP2841228B2 (en) * 1990-03-31 1998-12-24 雪印乳業株式会社 Process for producing liquid fermented milk and lactic acid bacteria beverage containing galactomannan hydrolyzate
JPH099985A (en) * 1996-07-17 1997-01-14 Meiji Seika Kaisha Ltd Food containing low-viscosity hardly digestible polysaccharides

Also Published As

Publication number Publication date
JP4283276B2 (en) 2009-06-24
WO2005110107A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
JP4772131B2 (en) Method for producing fermented milk using novel lactic acid bacteria
KR101277075B1 (en) Fermented food containing bifidobacterium bacteria and method for producing the same
CN107897371A (en) One kind is without sucrose flavored fermented milk
EP1901612A1 (en) Fermented food products containing probiotic strains and method for preparing same
JP4283276B2 (en) Fermented milk
CN111955548B (en) Pure probiotic flavored fermented milk and preparation method thereof
CN107937317B (en) Lactobacillus delbrueckii subsp bulgaricus, application thereof and yoghourt prepared from lactobacillus delbrueckii subsp bulgaricus
CN106615101A (en) Stirring type preparation process of stirring type active probiotic flavored fermented milk
CN109892390A (en) A kind of brown fermented milk-containing drink preparation method of the high lactic bacteria activity of low sugar
JP2016189709A (en) Method for producing fermented milk
JP2007105017A (en) Lactobacillus-fermented milk, and method for producing the same
JP5268916B2 (en) Acid lactic acid bacteria beverage, method for producing acid lactic acid bacteria beverage, and method for improving survival of bifidobacteria
JP3013157B2 (en) Lactic acid bacteria fermented milk material with suppressed increase in lactic acidity
JP7232177B2 (en) Method for producing lactic acid bacteria starter and fermented milk
JP4794592B2 (en) New lactic acid bacteria
CN107897372A (en) A kind of stirred type acidified milk and preparation method thereof
CN111213715B (en) Preparation method of brown viable bacteria type fermented milk with long shelf life and fermented milk
JP2002095409A (en) Fermented milk food
JP4794593B2 (en) Method for producing fermented milk using novel lactic acid bacteria
JP4248993B2 (en) Method for producing pasteurized fermented milk having stringing viscosity
JP2010273657A (en) Lactic acid drink and method for producing the same
JP7089818B1 (en) Lactic acid bacteria starter and fermented milk obtained by using it
CN115997822B (en) Lactobacillus reuteri normal-temperature yoghourt and preparation method thereof
JP2013192470A (en) Food and drink containing lactobacillus with high survival rate and method for producing the same
JP6966275B2 (en) How to improve the survival of lactic acid bacteria

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090310

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090318

R150 Certificate of patent or registration of utility model

Ref document number: 4283276

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120327

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120327

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130327

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130327

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140327

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees